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Angiogenesis relies on the ability of endothelial cells (ECs) to migrate over the
extracellular matrix via integrin receptors to respond to an angiogenic stimulus. Of
the two neuropilin (NRP) orthologs to be identified, both have been reported to be
expressed on normal blood and lymphatic ECs, and to play roles in the formation of
blood and lymphatic vascular networks during angiogenesis. Whilst the role of NRP1
and its interactions with integrins during angiogenesis has been widely studied, the role
of NRP2 in ECs is poorly understood. Here we demonstrate that NRP2 promotes Rac-1
mediated EC adhesion and migration over fibronectin (FN) matrices in a mechanistically
distinct fashion to NRP1, showing no dependence on β3 integrin (ITGB3) expression, or
VEGF stimulation. Furthermore, we highlight evidence of a regulatory crosstalk between
NRP2 and α5 integrin (ITGA5) in ECs, with NRP2 depletion eliciting an upregulation of
ITGA5 expression and disruptions in ITGA5 cellular organization. Finally, we propose a
mechanism whereby NRP2 promotes ITGA5 recycling in ECs; NRP2 depleted ECs were
found to exhibit reduced levels of total ITGA5 subunit recycling compared to wild-type
(WT) ECs. Our findings expose NRP2 as a novel angiogenic player by promoting
ITGA5-mediated EC adhesion and migration on FN.
Keywords: Neuropilins, endothelium, integrins, protein trafficking, cell migration
INTRODUCTION
Neuropilins (NRPs) are single non-tyrosine kinase receptors belonging to a family of type
I transmembrane glycoproteins (MW ∼130–140 kDa) (Soker et al., 1998). To date, two
NRP orthologs have been identified in vertebrates, NRP1 and NRP2, both of which share
a very similar domain structure and an overall 44% amino acid homology (Pellet-Many
et al., 2008; Zachary, 2014). Their expression and function have been identified in many cell
types, including nerve cells, endothelial cells (ECs), epithelial cells, immune cells, osteoblasts
and tumor cells (Bielenberg et al., 2004; Zachary, 2014). In ECs, it is believed that NRPs
play an essential role in sprouting angiogenesis and lymphogenesis through the selective
binding to members of the vascular endothelial growth factor (VEGF) family. Following this
complex formation, NRPs function as co-receptors with VEGFRs to enhance the VEGF-induced
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activation of many intracellular pathways (Prahst et al., 2008). As
such, the functions of NRP have been implicated in influencing
cell adhesion, migration and permeability during angiogenesis,
under both physiological and pathological conditions (Fukasawa
et al., 2007; Valdembri et al., 2009; Ellison et al., 2015).
Studies have, however, provided evidence to suggest that NRPs
can mediate ligand signaling independently of VEGFRs, in
addition to regulating VEGFRs independently of VEGF binding.
Based on early transgenic mouse studies in this field, it
was originally speculated that NRP1 is mainly expressed on
arteries, arterioles and capillaries, whereas NRP2 is expressed
on veins, venules and lymphatic vessels (Herzog et al.,
2001; Yuan et al., 2002). However, subsequent studies have
revealed that both NRPs are expressed in normal blood and
lymphatic ECs, and both play essential roles in forming
blood and lymphatic vasculature networks (Bouvree et al.,
2012; Jurisic et al., 2012; Mucka et al., 2016). Despite this,
investigations into elucidating the roles of endothelial NRPs
during angiogenesis have, for the most part, focused on
NRP1 (Zachary, 2014). With regard to NRP2, studies have
instead focused on annotating a role in cancer cells, where
its upregulation is consistent with cancer progression in a
number of cell types [e.g., neuroblastomas (Fakhari et al.,
2002), non-small cell lung carcinoma [NSCLC] (Kawakami
et al., 2002), human prostate carcinoma, melanoma (Bielenberg
et al., 2004), lung cancer (Tomizawa et al., 2001; Kawakami
et al., 2002; Lantuejoul et al., 2003), myeloid leukemia
(Vales et al., 2007), breast cancer (Bachelder et al., 2001)
and pancreatic cancer (Fukahi et al., 2004)]. Interestingly,
Favier et al. (2006) recapitulated this upregulation of NRP2
observed in cancer cells by overexpressing NRP2 in human
microvascular ECs (hMVECs), and found that cell survival in
these ECs was significantly increased following stimulation with
either VEGF-A- or VEGF-C. Furthermore, NRP2 knockdown
significantly inhibited both VEGF-A- and VEGFC-induced
migration, suggesting that NRP2 as a potential pharmacological
target. Crucially, this work highlighted the importance of
understanding the cross-talk between NRP2 and other receptors
(mainly VEGF, integrins and plexins) in ECs, which will
aid in the design of novel drugs to better control the
mechanisms underlying angiogenesis and lymphangiogenesis in
autoimmune diseases and tumor development (Favier et al.,
2006). We have previously described a link between NRP1
and the β3-integrin (ITGB3) subunit during VEGF-induced
angiogenesis. We reported that complete loss of the Itgb3
gene enhanced EC permeability through the upregulation of
VEGF-VEGFR2-ERK1/2 signaling (Robinson et al., 2004), and
that NRP1 and ERK1/2 expression was elevated in ITGB3-NULL
ECs. Subsequent targeting of NRP1 in ITGB3-NULL mice
revealed a significant inhibition of VEGF-induced angiogenesis
compared to WT mice, indicating that the elevation of
angiogenesis in the absence of the Itgb3 gene is dependent on
NRP1 expression (Robinson et al., 2009; Ellison et al., 2015). In
this study we aimed to investigate whether NRP2 shares a similar
interaction with ITGB3 or other integrins in ECs.
RESULTS
NRP2 Function Is Not Regulated by
ITGB3 During VEGFR2-Mediated
Signaling or Migration Over FN Matrices
We previously showed the involvement of NRP1 during
VEGF-stimulated angiogenesis to be dependent upon ITGB3
in ECs (Ellison et al., 2015). Due to the structural homology
between NRP1 and NRP2 (Zachary, 2014), we decided to
first consider whether, like NRP1, NRP2’s function shares
a dependency on ITGB3 during VEGF-mediated angiogenic
responses in ECs. To investigate this, we isolated mouse
lung microvascular endothelial cells (mLMECs) from both
wild-type (WT) and ITGB3-heterozygous (β3HET) mice and
immortalized them with polyoma-middle-T antigen (PyMT) by
retroviral transduction. As in previous studies, we decided to
use β3HET cells for these analyses, rather than β3-integrin
knockout (β3NULL) cells, because we have shown they are
a good model for studying the role of αvβ3-integrin in cell
migration, whilst evading changes arising from the complete
loss of the integrin on both alleles (e.g., up-regulated VEGFR2
expression) (Ellison et al., 2015; Atkinson et al., 2018). DNA
was extracted from multiple immortalized lines and analyzed
by PCR to confirm their genetic status as either WT or β3HET
cells (Supplementary Figure S1A). We subsequently confirmed
the EC identity of each immortalized line by examining the
expression of EC markers including VE-Cadherin (Sivarapatna
et al., 2015; Ikuno et al., 2017), in addition to quantifying the
expression of ITGB3 in β3HET ECs. Each clone was confirmed
to express canonical EC markers, and all β3HET ECs were
confirmed to express approximately 50% ITGB3 compared to
their WT counterparts (Supplementary Figures S1B–D). We
reported previously that in β3HET ECs, NRP1 expression is
upregulated, and that NRP1 appeared only to play a role
in post development angiogenesis when ITGB3 expression is
reduced (Ellison et al., 2015). Western blot quantification of
NRP2 expression between WT and β3HET protein lysates
showed a similar elevation in NRP2 expression in β3HET
ECs (Figure 1A), suggesting the existence of a regulatory
nexus between NRP2 and ITGB3, which we felt warranted
further exploration.
As NRP2 has been shown to regulate VEGF-induced
signaling in both human lymphatic (Caunt et al., 2008), and
lymphatic microvascular ECs, we examined whether NRP2
regulates proangiogenic signaling responses to VEGF and if the
effects are dependent on ITGB3. Using NRP2 specific siRNA
(Supplementary Figure S1E) versus a control siRNA transfected
into our WT and β3HET ECs, we measured differences in
VEGFR2 and ERK phosphorylation over a time course of 15 min.
We observed only marginally attenuated VEGFR2 and ERK
phosphorylation by Western blot analysis in response to NRP2
silencing and, importantly, saw no differences between WT and
β3HET ECs (Figure 1B), suggesting that ITGB3 does not regulate
NRP2 dependent VEGF induced signaling in our cells.
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FIGURE 1 | NRP2 is not regulated by ITGB3 during VEGFR2-mediated signaling or during migration over FN. (A): WT and β3HET ECs were plated onto FN and
incubated for 48 h at 37◦C and 5% CO2. EC extracts were immunoblotted using antibodies to NRP2, ITGB3 and HSC70. N = 3 independent experiments,
****P < 0.0001. (B,C): siRNA-transfected ECs were plated onto FN and incubated for 48 h at 37◦C and 5% CO2. ECs were subsequently starved in serum-free
media and stimulated with VEGF (30 ng/ml) for the indicated timepoints. EC extracts were immunoblotted using antibodies to phospho-VEGFR2, VEGFR2, NRP2,
NRP1, HSC70, phospho-ERK and ERK. N = 6 independent experiments, P > 0.05 (nsd). Left panel shows representative Western blot images, right panel shows
densitometric analysis of band intensities normalized against HSC70 and obtained using ImageJTM. Asterisks indicate statistical significance, nsd indicates no
significant difference from unpaired two-tailed t-tests. (C): siRNA-transfected ECs were seeded onto FN and incubated for 3 h at 37◦C and 5% CO2. Fixed images
were taken every 10 min for 15 h at 37◦C and 5% CO2 using an inverted Zeiss Axiovert microscope with one-phase contrast. Random migration speed was
quantified using the ImageJTM plugin mTrackJ in µm/hour. N = 4 independent experiments, n ≥ 30 ECs per experimental condition, ****P < 0.0001.
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To explore the possibility of a regulatory axis between
NRP2 and ITGB3 further, we examined cellular migration.
Angiogenesis relies on the ability of ECs to respond to angiogenic
stimuli by migrating over an extracellular matrix (ECM). We
have shown previously that NRP1 plays a role in promoting
EC migration over fibronectin (FN) matrices, but only when
ITGB3 levels are reduced (Ellison et al., 2015). Independent
studies have also described NRP2 silencing to inhibit migration
of human microvascular ECs (Favier et al., 2006) and human
lymphatic ECs (Caunt et al., 2008). We therefore chose to
examine the effects of NRP2 depletion on EC migration over
FN in our mLMECs, and to determine whether any effect is
dependent upon ITGB3 expression. To achieve this, control and
NRP2 siRNA transfected WT and β3HET ECs were plated on
FN and random migration speed was measured by time-lapse
microscopy over 15 h. As previously reported, we observed
β3HET ECs migrate faster over a FN matrix than WT ECs
(Ellison et al., 2015). However, unlike NRP1, whilst depletion
of NRP2 significantly reduced EC migration speed, it did so
independently of ITGB3 expression (Figure 1C). We therefore
conclude that ITGB3 does not regulate NRP2 function during
these angiogenic processes.
Depletion of NRP2 in ECs Disrupts
Adhesion to FN Matrices
Whilst the upregulation of NRP2 expression we observe in
β3HET ECs suggests a regulatory crosstalk between NRP2 and
ITGB3 (Figure 1A), NRP2 regulated signaling and migration
show no dependence on ITGB3. As NRP2 depletion significantly
impaired the ability of ECs to migrate over FN (Figure 1C),
but not to undergo proliferation (Supplementary Figure S2A)
we next chose to directly examine the effect of NRP2 depletion
on cell adhesion to FN. To do this we compared the relative
number of cells adhered to 96-well plates pre-coated with
FN for either 15 or 30 min. At both timepoints significantly
fewer cells adhered to FN following NRP2 siRNA treatment
compared to control siRNA treated ECs (Figure 2A and
Supplementary Figure S2B). Migration is dependent on the
ability of cells to adhere to a matrix via the formation
of FA complexes that continuously cycle through phases of
assembly and disassembly. FAs comprise a module of recruited
intracellular proteins, such as paxillin and integrins, that link
to the actin cytoskeleton to mediate mechanical changes in
the cell (Small et al., 1998; Webb et al., 2002; Valdembri
and Serini, 2012; De Pascalis and Etienne-Manneville, 2017).
Whilst NRP2 depletion had no effect on total or phosphorylated
levels of paxillin in our ECs (Figure 2B), we did observe it
to negatively impact the rate of focal adhesion (FA) turnover
itself. FA assembly and disassembly were monitored in ECs
treated with either control or NRP2 siRNAs, transfected with
paxillin-GFP, by time-lapse microscopy for 30 min over a FN
matrix. Silencing of NRP2 in mLMECs significantly reduced
the rate of both FA assembly and disassembly compared to
control siRNA treated cells (Figure 2C). We also measured
FA number and size distribution in ECs using two different
NRP2 siRNAs by immunolabelling for endogenous paxillin
in cells that had adhered to FN for 90 min, a time that
allows for mature FAs to form (Ridley et al., 2003; Schiller
et al., 2013; Atkinson et al., 2018). Despite no significant
difference in average cell area (Supplementary Figure S2C),
FAs were significantly fewer in number and smaller in average
size in NRP2 siRNA treated cells compared to control siRNA
treated ECs (Figure 2D, Supplementary Figure S2D), suggesting
NRP2 depletion inhibits FA maturation. Finally, we considered
whether NRP2 promotes EC adhesion and migration on FN
by regulating Rac1 activation. Rac1 is a small Rho GTPase
that mediates cell motility following integrin engagement,
regulating leading edge cytoskeletal dynamics and promoting
the formation of FAs (Nobes and Hall, 1995; Price et al., 1998;
Suzuki-Inoue et al., 2001; Ridley, 2011). Using a recombinant
PBD-domain protein (PAK-1) fused to glutathione-magnetic
beads, we captured the relative abundance of active Rac1-
GTP in control and NRP2 siRNA treated ECs stimulated for
180 min on FN. Compared to our control siRNA treated
ECs, NRP2 depleted ECs exhibited a significantly reduced
level of active Rac1 (Figure 2E), suggesting that NRP2
promotes EC adhesion and migration on FN by regulating
Rac1 activation.
NRP2 Regulates ITGA5 Expression in
ECs
Cells adhere to the ECM via heterodimeric integrin receptors,
which are recruited to FA complexes during cell migration
(Avraamides et al., 2008; Goel et al., 2012) and which activate
Rho family GTPases such as Rac1 (Price et al., 1998; Suzuki-Inoue
et al., 2001). α5β1 integrin is the principle FN binding integrin
in ECs (Valdembri et al., 2009; Valdembri and Serini, 2012),
and has been previously described as being upregulated during
developmental angiogenesis to promote EC migration and
survival (Kim et al., 2002; Goodman and Picard, 2012). Studies
have also shown NRP1, through its cytoplasmic SEA motif,
to specifically promote α5β1 integrin-mediated EC adhesion
to FN matrices in a VEGF independent fashion (Valdembri
et al., 2009; Cao et al., 2013). As NRP2 depletion significantly
impaired mLMEC migration and adhesion on FN, and given
the structural homology shared between NRP1 and NRP2,
we considered whether a similar association exists between
NRP2 and α5β1 integrin. First, we examined whether NRP2
knockdown regulated the expression of either integrin subunit.
Western blot analysis revealed that siRNA-mediated silencing
of NRP2 resulted in a significant upregulation of ITGA5
subunit expression in four different EC lines (Figure 3A),
whilst β1-integrin (ITGB1) expression remained unchanged
(data not shown). Whilst endothelial ITGA5 specifically pairs
with ITGB1 (Avraamides et al., 2008), ITGB1 can form
heterodimers with α subunits 1–9 (with the exception of α7)
(Velling et al., 1996; Hynes, 2002), suggesting α5β1-integrin
behavior can be studied by examining ITGA5 discretely (e.g.,
ITGB1 expression profiles are sum measures of its interactions
with multiple α subunits present in the cell). Therefore, we
chose to subsequently focus our attentions on ITGA5 and its
interplay with NRP2.
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FIGURE 2 | Depletion of NRP2 in ECs disrupts migration and adhesion to FN matrices by affecting Rac1 activation (A): siRNA-transfected ECs were seeded onto
FN coated 96-well plates pre-blocked with 5% bovine serum albumin (BSA), and incubated for either 15 or 30 min at 37◦C and 5% CO2. ECs were subsequently
fixed in 4% PFA and stained with methylene blue. Absorbance was read at 630 nm. Data was normalized to the relative number of the total cells seeded in a 3-h
incubation control plate. N = 3 independent experiments, **P < 0.01, ***P < 0.001. Asterisks indicate statistical significance from unpaired two-tailed t-tests.
(B) siRNA-transfected ECs were plated onto FN and incubated for 48 h at 37◦C and 5% CO2. EC lysates were immunoblotted using antibodies to NRP2,
phospho-paxillin, paxillin and GAPDH. (C) siRNA-transfected ECs were double transfected with a GFP paxillin construct, seeded onto FN and incubated for 48 h at
37◦C and 5% CO2. ECs were fixed in a Ludin chamber and live imaged at 37◦C and 5% CO2 using an inverted Axiovert microscope in which an individual
(Continued)
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FIGURE 2 | Continued
cell was captured every one minute for 30 min (left panels). Focal adhesion (FA) assembly and disassembly speeds were analyzed using the ImageJTM plugin
mTrackJ in µm/min. In each respective bar, n ≥ 100 FAs, **P < 0.01 (right panel). (D) siRNA-transfected ECs were seeded onto FN and incubated for 90 min at
37◦C and 5% CO2 before being fixed and stained for paxillin. Images were taken using a Zeiss AxioImager M2 microscope at 63x magnification. FA number and size
was quantified using ImageJTM software as previously described by Lambert et al. (2020). A FA size lower detection limit was set at 0.8 microns. The center panel
shows representative images for fixed ECs transfected either with control or NRP2 siRNA. Image quantification for FA number and size is shown in the left panel.
Quantification performed on mean data from n ≥ 25 ECs over N = 3 independent experiments. % FA size distribution analysis is shown in the right panel on mean
data from n ≥ 25 ECs over N = 3 independent experiments. Asterisks indicate statistical significance from an unpaired two-tailed t-test. (E) siRNA-transfected ECs
were seeded onto FN and incubated for 180 min at 37◦C and 5% CO2. EC extracts were immunoprecipitated by incubation with 10 µg Rac1 assay reagent (PAK-1
PBD magnetic beads) for 45 min at 4◦C with gentle agitation. Immunoprecipitated complexes were subjected to Western blot analysis using antibodies against
Rac1. Left panel: low and high exposure images showing active Rac1 levels in control and NRP2 siRNA transfected lysate. Middle panel: NRP2 depletion was
confirmed by Western blot analysis using antibodies against NRP2 and GAPDH. Right panel: densitometric analysis of band intensities normalized against GAPDH
and obtained using ImageJTM. Asterisks indicate statistical significance from an unpaired two-tailed t-test.
Studies have previously reported NRP1 to complex with
ITGA5 in HUVECs (Valdembri et al., 2009) and NRP2 to
complex with ITGA5 from co-cultures between HUVECs and
renal cell carcinoma (Cao et al., 2013). To investigate whether a
direct interaction between NRP2 and ITGA5 exists in mLMECs,
lysates were subjected to a series of co-immunoprecipitation
studies followed by Western blot analysis. We found both
NRP2 and ITGA5 co-immunoprecipitate with each other,
indicating a physical interaction between the two receptors
(Figure 3B). Immuno-staining using a highly specific NRP2
antibody, reported previously not to cross-react with NRP1
(Bae et al., 2008; Goel et al., 2012), also showed a strong
co-localization between NRP2 and ITGA5 close to the cell
membrane (Figure 3C). Given the significant upregulation
of ITGA5 subunit expression following NRP2 depletion, and
evidence to suggest a physical interaction between NRP2 and
ITGA5, we next examined whether NRP2 depletion elicited
an effect on ITGA5 localization within our immortalized cells.
Following treatment with either control or NRP2 siRNA, ECs
were seeded overnight on a FN matrix and subsequently
fixed to visualize endogenous ITGA5 expression. Compared
to control siRNA treated ECs, NRP2 depleted ECs exhibited
significant disruptions in ITGA5 organization: ITGA5 appeared
in elongated fibrillar-like structures (Figure 3D), reminiscent
of what has been described as fibrillar adhesions (Webb et al.,
2002). ImageJTM analysis of these ITGA5 containing structures
confirmed a significant increase in the length of ITGA5 fibrils in
NRP2 siRNA treated ECs suggestive of a disruption in ITGA5
trafficking (Supplementary Figure S3A). We see this NRP2-
dependent ITGA5 phenotype when using multiple NRP2 specific
siRNAs (Supplementary Figure S3B) and in primary ECs
(Supplementary Figures S3C,D). It is becoming increasingly
clear that microtubule-actin highways co-ordinately regulate a
range of intracellular trafficking mechanisms, including integrin
transport (Goley and Welch, 2006; Kaksonen et al., 2006;
Valdembri et al., 2009; Zech et al., 2011; Duleh and Welch,
2012). Co-immunostaining for both phalloidin and ITGA5
revealed that whilst ITGA5 localized to the ends of actin
filaments in control treated ECs, at what we assume to be
FAs, in NRP2 depleted cells, the elongated ITGA5 fibrils share
a strong co-localization along the actin filaments themselves
(Figure 3E). We believe this to support a mechanism of
actin-dependent ITGA5 trafficking, whereby loss of NRP2
impedes the transport of ITGA5 to FAs at the leading
edge of the cell.
ITGA5 Trafficking Is Dependent on NRP2
in ECs
Whilst a role for NRP2 in trafficking ITGA5 is novel, NRP1 has
been shown previously to promote endocytosis of active α5β1
integrin through a Rab5 pathway (Valdembri et al., 2009). In
order to take an unbiased approach to elucidating candidate
trafficking proteins NRP2 may associate with to regulate
ITGA5 localization in ECs, we used label-free quantitative
(LFQ) mass spectrometry. Mass spectrometry was performed
on two WT EC lines, transfected either with control or NRP2
siRNA, and immunoprecipitated for NRP2. siRNA-mediated
depletion of NRP2 was confirmed for both cell lines. This
analysis revealed proteins immunoprecipitating with NRP2 at
a significantly increased fold-change compared to proteins
analyzed from a NRP2 knockdown cell-lysate. Shown are protein
hits detected in both cell lines, including both ITGA5 and ITGB1.
A number of endocytic trafficking proteins were also detected
as candidate binding partners of NRP2, including clathrin,
caveolin-1, lamtor1, scamp1, and annexin-A1 (Figure 4A). The
full list of identified co-immunoprecipitated proteins is shown in
Supplementary Table S1.
α5β1 integrin is known to be internalized both by clathrin
and caveolae-mediated endocytosis (Shi and Sottile, 2008;
Margadant et al., 2011). In order to validate a potential
mechanism by which NRP2 regulates ITGA5 internalization
via its contact with clathrin and caveolin, we performed
coimmunoprecipitation assays to prove a physical interaction.
NRP2 coimmunoprecipitated with both clathrin heavy chain-1
and caveolin-1 (Figure 4B), supporting the mass spectrometry
results. We subsequently conducted cell surface biotinylation
assays to examine ITGA5 internalization directly, in ECs treated
either with control siRNA or NRP2 siRNA. We observed
no change in the rate of ITGA5 internalization in NRP2
depleted ECs (Figure 4C), suggesting that NRP2 does not
regulate internalization of total ITGA5 levels. We subsequently
considered whether NRP2 regulates ITGA5 recycling back
to the membrane.
Integrin recycling is mediated by Rab GTPase proteins
(Roberts et al., 2001; Paul et al., 2015), specifically, α5β1
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FIGURE 3 | NRP2 regulates ITGA5 expression in ECs. (A): siRNA-transfected ECs from four different clones were seeded onto FN and incubated for 48 h. EC
extracts were immunoblotted using antibodies to ITGA5, NRP2, and HSC70. Left panel shows Western blot image, right panel shows densitometric analysis of
ITGA5 band intensities normalized against HSC70 and obtained using ImageJTM. **P < 0.01. (B): siRNA-transfected ECs were seeded onto FN and incubated for
48 h. Left panel: EC extracts were immunoprecipitated by incubation with protein-G Dynabeads R© coupled to a NRP2 antibody. Middle panel: EC extracts were
immunoprecipitated by incubation with protein-G Dynabeads R© coupled to two different ITGA5 antibodies (as indicated). Immunoprecipitated complexes
were subjected to Western blot analysis using antibodies against ITGA5 and NRP2, respectively. Right panel: NRP2 silencing was confirmed by subjecting the total cell
(Continued)
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FIGURE 3 | Continued
lysate to Western blot analysis and incubating blots in antibodies against NRP2 and HSC70. (C): Control siRNA-transfected ECs were prepared as described in
Figure 2D legend. Fixed ECs were incubated in primary antibodies against NRP2 and ITGA5. Images were captured using a Zeiss AxioImager M2 microscope at
63x magnification. Arrows indicate co-localization of NRP2 and ITGA5. (D): siRNA-transfected ECs were prepared as described in Figure 2D legend, however, ECs
were allowed to adhere overnight prior to fixation. ECs were incubated in primary antibody against ITGA5. (E) siRNA-transfected ECs were prepared as described in
(D), however, fixed cells were incubated in ITGA5 primary antibody and phalloidin-364. Arrows indicate localization of ITGA5 with actin filaments. Image panels
shown in (C–E) are representative of n ≥ 10 cells per condition/treatment.
integrin follows long-loop recycling via a Rab11 dependent
mechanism (Laukaitis et al., 2001; Caswell et al., 2007).
NRP2 coimmunoprecipitated with Rab11 in both directions
(Figure 4D). However, NRP2 did not co-immunoprecipitate
with NRP1 in our mass spec studies (see Supplementary
Table S1), suggesting these two structurally related proteins
regulate ITGA5 trafficking through distinct pathways. As
our mass spectrometry analysis had identified candidate
interactions between NRP2 and other trafficking and recycling
molecules, such as Rab11Fip5, an adaptor for Rab11 recycling
vesicles and previously reported to co-immunoprecipitate
with ITGA5, we performed biotin recycling assays. In these
assays, the biotin-labeled cell surface proteins were allowed
to internalize before stripping off any remaining surface
biotin. Cells were then incubated over 20 min to stimulate
the recycling process. In contrast to our internalization
assays, NRP2 silencing significantly attenuated the rate of
total ITGA5 recycling back to the membrane compared
to ECs treated with control siRNA (Figure 4E). We
therefore present a potential mechanism whereby NRP2
promotes mLMEC migration and adhesion to FN by
regulating actin dependent ITGA5 recycling back to the
cell membrane (Figure 5).
DISCUSSION
NRP2 is known to regulate ECM adhesion and migration
in various cell lines, including human ECs (Favier et al.,
2006), immune cells (Curreli et al., 2007) and cancer cells
(Kawakami et al., 2002; Fukahi et al., 2004; Caunt et al.,
2008; Dallas et al., 2008; Cao et al., 2013). In the latter, it
has been described as a biomarker for poor prognosis because
its expression correlates with increased migratory and invasive
behavior (Kawakami et al., 2002; Caunt et al., 2008; Dallas
et al., 2008; Cao et al., 2013). In many of these examples, NRP2
promotes cell adhesion and migration by exerting influence over
VEGF-mediated pro-angiogenic pathways and inducing integrin
engagement. ITGA5 and FN are known to be upregulated in
ECs during angiogenesis (Kim et al., 2002; Goodman and Picard,
2012), and are key players in formation of neo-vasculature
(Brooks et al., 1994; Kim et al., 2000). The data we present
here support a model whereby NRP2 promotes EC adhesion
and migration on FN by regulating actin-dependent ITGA5
recycling. Importantly, the means by which it does so appears to
be mechanistically distinct from that of NRP1, which is known
to regulate internalization of active ITGA5 via a rab5-dependent
pathway (Valdembri et al., 2009).
We previously demonstrated an ITGB3-dependent role for
NRP1 in mediating EC migration and FA turnover on FN. EC
migration on FN becomes NRP1 dependent when ITGB3 levels
are perturbed (Ellison et al., 2015). Like NRP1, NRP2 expression
is upregulated in ITGB3 depleted cells (Figure 1A). Given this
observation, and the structural and domain homologies between
NRP1 and NRP2 (Zachary, 2014), we sought to investigate
whether NRP2 shared a similar regulatory interplay with ITGB3.
We demonstrated by siRNA knockdown that EC migration
depends on NRP2, but this is independent of ITGB3 expression
levels (Figure 1C).
Like NRP1, NRP2 also regulates a number of
integrin-dependent cellular processes on FN. Upon NRP2
knockdown, EC adhesion is reduced (Figure 2A), FA
dynamics are altered (Figures 2C,D), and Rac1 activation
is impaired (Figure 2E). Rac1 was also identified from our
mass spectrometry analysis as a candidate binding partner
of NRP2, which supports these findings. Integrins provide
the structural link that allows for: (1) adhesion to the ECM;
(2) anchorage of actin stress fibers to the membrane; (3) the
generation of force that is required for migration (Laukaitis
et al., 2001; Le Boeuf et al., 2004; Buskermolen et al., 2018).
Both αvβ3- and α5β1-integrins are FN receptors in ECs (Brooks
et al., 1994; Kim et al., 2000), but given the lack of any ITGB3
input into the NRP2 processes we were examining, and the
upregulation of ITGA5 expression upon NRP2 depletion
(Figure 3A), we focused our attention on this integrin subunit.
Cao et al. (2013) demonstrated NRP2 to interact with ITGA5
in co-cultures between HUVECs and renal cell carcinoma to
promote FN-mediated adhesion. To our knowledge, though,
we are the first to show evidence of a direct interaction between
NRP2 and ITGA5 in microvascular ECs (Figures 3B,C).
Furthermore, our findings demonstrate that NRP2 modulates
ITGA5 function by regulating its subcellular trafficking
along the actin cytoskeleton. Importantly, the disrupted
ITGA5 phenotype we see following NRP2 depletion in our
immortalized ECs is also present in primary ECs. Along with
our previous studies demonstrating they express a canonical
adhesome (Atkinson et al., 2018), this rebuts the concept that
immortalized ECs are an inappropriate model for studying
angiogenic processes.
NRP2’s role in trafficking ITGA5 in ECs also appears to be
distinct from that of NRP1. It has been reported that NRP1
regulates active α5β1 integrin endocytosis via GIPC1 (Valdembri
et al., 2009), however, interactions between GIPC and NRP2
were not detected from either mass spectrometry analysis or
co-immunoprecipitation studies (data not shown). Although we
did not observe any changes in internalization of total ITGA5
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FIGURE 4 | ITGA5 trafficking in ECs is NRP2 dependent. (A): Label-free quantitative mass spectrometry peptide hits identified using MaxQuant software from the
Andromeda peptide database. Panel depicts peptide hits detected at a higher fold-change in two control siRNA treated EC lines than those detected from two NRP2
siRNA treated EC lines. NRP2 silencing was confirmed by subjecting EC extracts to Western blot analysis. (B): siRNA-transfected ECs were seeded onto FN and
incubated for 48 h. EC extracts were immunoprecipitated by incubation with protein-G Dynabeads R© coupled to a NRP2 antibody. Immunoprecipitated complexes
were subjected to Western blot analysis using antibodies against clathrin heavy chain-1 (top) and caveolin-1 (bottom). (C): siRNA-transfected ECs were seeded onto
(Continued)
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FIGURE 4 | Continued
FN and incubated for 48 h. ECs were subsequently starved in serum-free media, before being placed on ice. EC cell surface proteins were labeled with 0.3 mg/ml
biotin. ECs were then incubated for the indicated timepoints at 37◦C, 5% CO2. A sample of ECs were maintained at 4◦C as (±Mesna) controls. Following incubation
at 37◦C, ECs were placed on ice and incubated with 100 mM Mesna. EC lysates were then immunoprecipitated with protein-G Dynabeads R© coupled to an
anti-biotin antibody. Immunoprecipitated biotin-labeled proteins were separated by SDS-PAGE and subjected to Western bolt analysis. The level of internalized
ITGA5 at each time of incubation was normalized to the (-) Mesna control. Left panel shows Western blot image, right panel shows the mean densitometric analysis
obtained using ImageJTM. Also shown is confirmation of NRP2 silencing. N = 3 independent experiments. (D): Co-immunoprecipitation study as described in (B),
immunoprecipitated complexes were subjected to Western blot analysis using anti-Rab11 and anti-NRP2 antibodies, respectively. (E): siRNA-transfected ECs were
prepared as described in (C), after biotin surface labeling, ECs were incubated in serum free media for 20 min at 37◦C to allow for internalization. A sample of ECs
were maintained at 4◦C for use as positive/negative controls. The remaining ECs were then placed on ice, and any un-internalized biotin-labeled proteins stripped off
using 100 mM Mesna. The internalized protein fraction was allowed to recycle by incubating the ECs for the indicated timepoints at 37◦C. ECs were then returned to
ice and incubated in 100 mM Mesna. No Mesna treatment dishes at each timepoint were used as comparative controls. All subsequent stages were performed in
the same manner as described in (C), the level of the recycled ITGA5 was determined by normalizing the amount of ITGA5 quantified from dishes treated with Mesna
to the total ITGA5 on the membranes of the Mesna-untreated cells in the same period of incubation. N = 3 independent experiments.
FIGURE 5 | Schematic summarizing the major results. (A), NRP2 and ITGA5 share an interaction at the cell membrane, promoting EC adhesion and migration on FN
matrices by regulating Rac1 activation. (B), NRP1 is known to selectively stimulate internalization of active α5β1 integrin from fibrillar adhesions along F-actin
microfilaments to early endosomes in a Rab5 dependent manner. (C) NRP2 then regulates Rab11 dependent recycling of total ITGA5 back to adhesion sites along
the actin cytoskeleton.
upon NRP2 depletion (Figure 4C), we were unable to examine
trafficking of active α5β1 in our murine cells. In fact, we
observed physical interactions between NRP2 and both clathrin
and caveolin by immunoprecipitation (Figure 4B) suggesting
NRP2 at least has the potential to regulate the endocytosis of
active α5β1 integrin. Following internalization by clathrin or
caveolin-dependent mechanisms, α5β1 integrin has been shown
to undergo long-loop recycling back to the membrane within
Rab11 positive vesicles (Laukaitis et al., 2001; Caswell et al., 2007).
To our knowledge neither NRP1 or NRP2 have been reported to
regulate ITGA5 recycling in microvascular ECs. Not only do we
show NRP2 depletion slows total ITGA5 recycling (Figure 4D),
we also show NRP2 co-immunoprecipitates with Rab11 in our
ECs (Figure 4E).
Finally, the elevated total cellular levels of ITGA5 that occur
when NRP2 is knocked-down, particularly in light of no changes
at the cell surface (data not shown), suggest other points in
the ITGA5 life cycle are governed by NRP2. Given NRP2’s
interactions with clathrin and caveolin, both known to play a role
in endosomal trafficking to lysosomes (Sachse et al., 2002; Shi
and Sottile, 2008; Margadant et al., 2011), we speculate a role for
the molecule in regulating ITGA5 degradation. We support this
hypothesis by showing NRP2 also immunoprecipitates with both
Lamtor1 and Scamp1 (Figure 4A), proteins previously shown to
regulate lysosomal trafficking (Cai et al., 2011; Malek et al., 2012).
In close, we propose a novel mechanism by which NRP2,
independently of its role as a coreceptor for VEGF-A, promotes
Rac1-mediated EC adhesion and migration to FN matrices by
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regulating recycling of ITGA5. Importantly, we provide evidence
to suggest that NRP2 acts in a mechanistically distinct manner
to NRP1. Finally, whilst we have not yet shown any phenotypic
interactions between NRP2 and ITGB3, we cannot rule out
a role for ITGB3 in regulating NRP2 trafficking. Like NRP1,
NRP2 levels are significantly elevated when ITGB3 expression
is reduced (Figure 1A). Our findings allude to a complex




All experiments were performed in accordance with
United Kingdom home office regulations and the European
Legal Framework for the Protection of Animals used for
Scientific Purposes (European Directive 86/609/EEC), prior
to the start of this project. Transgenic mice expressing a
knockout for the β3-integrin allele (KO-Itgb3) were generated by
substituting a 1.4 kb HindIII fragment of the β3 gene including
exons I and II with a 1.7 kb construct containing a Pgk-neomycin
(neo)-resistance cassette (Supplementary Figure S1G). The
PCR analysis was carried out using the following oligonucleotide
primers as previously described by Hodivala-Dilke et al. (1999).
Forward primer 1: 5′-CTTAGACACCTGCTACGGGC-3′
Reverse primer 2: 5′-CACGAGACTAGTGAGACGTG-3′.
Cell Isolation, Immortalization and Cell
Culture
Primary mouse lung microvascular endothelial cells (mLMECs)
were isolated from adult mice bred on a mixed C57BL6/129
background. Primary ECs were twice positively selected for their
expression of intracellular adhesion molecule-2 (ICAM-2) by
magnetic activated cell sorting (MACS) as previously described
by Reynolds and Hodivala-Dilke (Reynolds and Hodivala-Dilke,
2006). ECs were immortalized using polyoma-middle-T-antigen
(PyMT) retroviral transfection as previously described by
Robinson et al. (2009). Immortalized mLMECs were cultured
in IMMLEC media, a 1:1 mix of Ham’s F-12:DMEM medium
(low glucose) supplemented with 10% FBS, 100 units/mL
penicillin/streptomycin (P/S), 2 mM glutamax, 50 µg/mL
heparin (Sigma). Immortalized mLMECs were cultured on 0.1%
gelatin coated flasks at 37◦C in a humidified incubator with
5% CO2. For experimental analyses, plates, dishes, flasks and
coverslips were coated in 10 µg/ml human plasma fibronectin
(FN) (Millipore) overnight at 4◦C. Vascular endothelial growth
factor-A (VEGF-A164: mouse equivalent of VEGF-A165) was
made in-house as previously described by Krilleke et al. (2007).
siRNA Transfection
ECs were transfected with non-targeting control siRNA
or mouse-specific NRP2 siRNA constructs (Dharmacon),
suspended in nucleofection buffer (200 mM Hepes, 137 mM
NaCl, 5 mM KCl, 6 mM D-glucose, and 7 mM Na2HPO4
in nuclease-free water) using either the Amaxa nucleofector
system II (Lonza) under nucleofection program T-005 or the
Amaxa 4Dnucleofector system (Lonza) under nucleofection
program EO-100 according to manufacturer’s instructions. For
the majority of our studies we used siGENOME mouse Nrp2
siRNA D-040423-03 (denoted as Nrp2 siRNA on figures). We
confirmed key observations with siGENOME mouse Nrp2
siRNA D-040423-04 (denoted as Nrp2 siRNA#4 on figures).
Western Blot Analysis
siRNA transfected ECs were seeded into FN-coated 6-well plates
at a seeding density of 5 × 105 cells/well and incubated for
48 h at 37◦C in a 5% CO2 incubator. ECs were lysed in
electrophoresis sample buffer (ESB) (Tris–HCL: 65 mM pH 7.4,
sucrose: 60 mM, 3% SDS), and homogenized using a Tissue
Lyser (Qiagen) with acid-washed glass beads (Sigma). Following
protein quantification using the DC BioRad assay, 30 µg of
protein from each sample was loaded onto 8% polyacrylamide
gels and subjected to SDS-PAGE. Proteins were transferred to
a nitrocellulose membrane (Sigma) and incubated in 5% milk
powder in PBS 0.1% Tween-20 (0.1% PBST) for 1 h at room
temperature followed by an overnight incubation in primary
antibody diluted 1:1000 in 5% bovine serum albumin (BSA) in
0.1% PBST at 4◦C. Membranes were washed 3× with 0.1% PBST
and incubated in an appropriate horseradish peroxidase (HRP)-
conjugated secondary antibody (Dako) diluted 1:2000 in 5% milk
powder in 0.1% PBST for 2 h at room temperature. Membranes
were washed again 3× with 0.1% PBST before being incubated
with Pierce ECL Western Blotting Substrate solution (Thermo
Scientific). Chemiluminescence was detected on a ChemiDocTM
MP Imaging System darkroom (BioRad). Densitometric readings
of band intensities for blots were obtained using ImageJTM.
Primary antibodies (all used at 1:1000 dilution and purchased
from Cell Signaling Technology, unless noted otherwise)
were: anti-NRP2 (clone D39A5), anti-ITGB3 (clone 4702S),
anti-HSC70 (clone B-6, Santa Cruz Biotechnology), anti-phospho
VEGFR2 (Y1175) (clone 2478), anti-VEGFR2 (clone 2479),
anti-NRP1 (clone 3725S), anti-phospho ERK1/2 (clone 9101),
anti-ERK1/2 (clone 4695), anti-ITGA5 (clone 4705S), anti-
ITGB1 (clone ab179471, Abcam), anti-clathrin heavy chain-
1 (clone ab21679, Abcam), anti-caveolin-1 (clone ab18199,
Abcam), anti-Rab11 (clone 3539), ERG: Ab92513, Pecam-
1 (77699), prox-1 (clone ab11941, Abcam), claudin-5 (clone
ab131259, Abcam), VE-cadherin (clone ab205336, Abcam).
Signaling Assays
siRNA-transfected ECs were seeded into FN-coated 6 cm cultures
dishes at a density of 5 × 105 cells/well and incubated for 48 h at
37◦C and 5% CO2. ECs were then PBS washed and starved for
3 h in serum free medium (OptiMEM R©; Invitrogen). VEGF was
then added at a final concentration of 30 ng/ml. After the desired
time of VEGF-stimulation, ECs were subjected to lysing, protein
quantification and protein expression analysis by Western blot.
Random Migration Assays
siRNA-transfected ECs were seeded into FN coated 24-well plates
at a density of 7 × 104 cells/well 24 h post nucleofection, and
allowed to adhere for 3 h at 37◦C and 5% CO2. Fixed images
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of multiple fields/well were taken every 10 min for 15 h at
37◦C and 5% CO2 using an inverted Zeiss Axiovert microscope
with one-phase contrast. Random migration was quantified by
manually tracking individual cells using the ImageJTM plugin
mTrackJ. Random migration speed was calculated in µ m/hour.
Colorimetric Adhesion Assays
siRNA-transfected ECs were seeded into 96-well plates at a
density of 4 × 104 cells/well 48 h post nucleofection. 96-well
plates were pre-coated with FN overnight, then blocked in 5%
BSA for 1 h at room temperature. ECs were then incubated at
37◦C in a 5% CO2 incubator for the indicated timepoints, in
addition to a 3-h incubation control plate. Following incubation,
ECs were washed 3× with PBS + 1 mM MgCl2 + 1 mM CaCl2,
fixed in 4% PFA, and stained with methylene blue for 30 min
at room temperature. ECs were washed in dH2O and air-dried,
before the dye from stained adhered ECs was extracted by a
de-stain solution (50% ethanol, 50% 0.1 M HCL). The absorbance
of each well was then read at 630 nm. Data was normalized
to the relative number of the total cells seeded in the 3-h
incubation plate.
Focal Adhesion Turnover Assays
ECs double transfected with control or NRP2 siRNA and a
GFP-tagged paxillin construct (kindly provided by Professor
Maddy Parsons, Kings College, London) were seeded onto
FN-coated acid-washed, oven sterilized glass coverslips in 24-well
plates at a seeding density of 4 × 104 cells/well. 48 h post
nucleofection, coverslips were PBS washed, fixed in a Ludin
chamber (Life Imaging Services GmbH), and live imaged in
OptiMEM R© phenol-red free medium supplemented with 2% FBS
and P/S at 37◦C and 5% CO2 using an inverted Axiovert (Carl
Zeiss Ltd.) microscope in which an individual cell was captured
every one minute for 30 min. Focal adhesion (FA) assembly
and disassembly speeds were analyzed by manually tracking the
number of selected GFP-paxillin-positive focal adhesions using
the Image JTM MTrackJ plugin software.
Immunocytochemistry
siRNA-transfected ECs were seeded onto FN-coated
acid-washed, oven sterilized glass coverslips in 24-well plates
at a seeding density of 2.5 × 104 cells/well, and incubated at
37◦C and 5% CO2. ECs were fixed at indicated timepoints
in 4% paraformaldehyde (PFA) for 10 min, washed in PBS,
blocked and permeabilized with 10% goat serum, PBS 0.3%
triton X-100 for 1 h at room temperature. Cells were incubated
in primary antibody diluted 1:100 in PBS overnight at 4◦C.
Primary antibodies were: anti-paxillin (clone ab32084; Abcam),
anti-ITGA5 (clone ab150361; Abcam). Coverslips were PBS
washed, and incubated with donkey anti-rabbit Alexa fluor-488
secondary antibody diluted 1:200 in PBS for 2 h at room
temperature. F actin staining was performed by incubating cells
in phalloidin-564 diluted 1:40 in PBS for 2 h at room temperature
during secondary antibody incubation. Coverslips were PBS
washed again, before being mounted onto slides with Prolong R©
Gold containing DAPI (Invitrogen). Images were captured using
a Zeiss AxioImager M2 microscope (AxioCam MRm camera)
at 63× magnification. FA number and size was quantified using
ImageJTM software as previously described by Lambert et al.
(2020). A FA size lower detection limit was set at 0.8 microns.
ITGA5 length was measured using the ImageJTM software plugin
simple neurite tracer.
Rac1 Pulldown
siRNA-transfected ECs were seeded onto FN at a density of
2 × 105 cells/dish and incubated for 180 min at 37◦C and
5% CO2. ECs were lysed on ice with MLB (Sigma) (diluted to
1× with sterile water containing 10% glycerol and 1× HaltTM
protease inhibitor cocktail (Thermo Scientific). EC lysates were
cleared by centrifugation. EC extracts were immunoprecipitated
by incubation with 10 µg Rac1 assay reagent (PAK-1 PBD
magnetic beads, Sigma) for 45 min at 4◦C with gentle agitation.
Immunoprecipitated complexes were subjected to Western blot
analysis. Nitrocellulose membranes were immunoblotted using
1 µg/mL of anti-Rac1, clone 23A8 (Sigma).
Co-Immunoprecipitation Assays
siRNA-transfected ECs were seeded into FN-coated 10 cm dishes
at a density of 2 × 106 cells/dish, and incubated for 48 h
at 37◦C and 5% CO2. ECs were then lysed on ice in lysis
buffer as previously described by Valdembri et al. (2009) in
the presence of 1× Halt protease inhibitor cocktail (Thermo
Scientific) and protein quantified using the DC BioRad assay.
100 µg protein from each sample was immunoprecipitated by
incubation with protein-G Dynabeads R© (Invitrogen) coupled
to a rabbit anti-NRP2 antibody (clone 3366, Cell Signaling
Technology) on a rotator overnight at 4◦C. Immunoprecipitated
complexes were then washed 3× with lysis buffer + 1× HaltTM
protease inhibitor cocktail, and once in PBS, before being added
to and boiled in NuPAGE sample reducing agent and sample
buffer (Life Technologies) for Western blot analysis.
Co-localization Assays
siRNA-transfected ECs were prepared the same as for
immuno-cytochemistry. Cells were incubated in primary
antibody diluted 1:50 in PBS overnight at 4◦C. Primary
antibodies were: anti-NRP2 (clone sc-13117, Santa Cruz
Biotechnology), and anti-ITGA5 (clone ab150361; Abcam).
Coverslips were PBS washed, and incubated with both donkey
anti-rabbit Alexa fluor-488, and goat anti-mouse Alexa fluor-546
secondary antibodies diluted 1:200 in PBS for 2 h at room
temperature. Coverslips were PBS washed again, before being
mounted onto slides with Prolong R© Gold containing DAPI
(Invitrogen). Images were captured using a Zeiss AxioImager M2
microscope (AxioCam MRm camera) at 63×magnification.
Mass Spectrometry Analysis
NRP2 co-immunoprecipitation samples were sent to Fingerprints
Proteomics Facility (Dundee University, United Kingdom),
which carried out LFQ mass spectrometry and peptide
identification using the MaxQuant software based on the
Andromeda peptide database as described by Schiller et al.
(2011). Figure 4A depicts peptide hits detected at a higher
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fold-change in two control siRNA treated EC lines than those
detected from two NRP2 siRNA treated EC lines.
Internalization and Recycling Assays
Internalization
siRNA-transfected ECs were seeded into FN-coated 10 cm dishes
at a density of 2 × 106 cells/dish, and incubated for 48 h
at 37◦C and 5% CO2. ECs were then starved in serum-free
OptiMEM R© for 3 h at 37◦C in a 5% CO2 incubator, before
being placed on ice for 5 min, then washed twice with Soerensen
buffer (SBS) pH 7.8 (14.7 mM KH2PO4, 2 mM Na2HPO4,
and 120 mM Sorbitol pH 7.8) as previously described by
Remacle et al. (2003). EC cell surface proteins were labeled
with 0.3 mg/ml biotin (Thermo Scientific) in SBS for 30 min
at 4◦C. Unreacted biotin was quenched with 100 mM glycine
for 10 min at 4◦C. ECs were then incubated in pre-warmed
serum-free OptiMEM R© for the indicated time points at 37◦C
in a 5% CO2 incubator. A sample of ECs were maintained at
4◦C for use as positive/negative (±Mesna) controls. Following
incubation, dishes were immediately placed on ice, washed twice
with SBS pH 8.2, and incubated with 100 mM Mesna (Sigma)
for 75 min at 4◦C (with the exception of Mesna control plates,
which were lysed in lysis buffer (25mM Tris–HCl, pH 7.4,
100 mM NaCl, 2mM MgCl2, 1mM Na3VO4, 0.5 mM EGTA,
1% Triton X-100, 5% glycerol, and protease inhibitors), and
placed on ice). Following Mesna incubation, excess Mesna was
quenched with 100mM iodoacetamide (Sigma) for 10 min at
4◦C, then ECs were washed twice with SBS pH 8.2 and lysed.
Lysates were cleared by centrifugation at 12,000 g for 20 min
at 4◦C. Supernatant proteins were then quantified using the
DC BioRad assay, and subsequently immunoprecipitated with
Dynabeads coupled to mouse anti-biotin antibody overnight at
4◦C. Immunoprecipitated biotin-labeled proteins were separated
by SDS-PAGE and subjected to Western bolt analysis. The level
of internalized ITGA5 at each time of incubation was normalized
to the (−Mesna) control.
Recycling
After surface labeling, ECs were incubated in pre-warmed
serum free OptiMEM R© for 20 min at 37◦C to allow
internalization. A sample of ECs were maintained at 4◦C
for use as positive/negative controls. The remaining dishes were
subsequently placed on ice, washed twice with SBS pH 8.2, and
any un-internalized biotin-labeled proteins were stripped off
using 100 mM Mesna in Tris buffer for 75 min at 4◦C. The
internalized fraction of proteins was then allowed to recycle
to the membrane by incubating the ECs for the indicated
time points in serum-free OptiMEM R© at 37◦C. Following the
indicated times of incubation, dishes were placed on ice, washed
twice with SBS pH 8.2, and subjected to Mesna incubation for
75 min at 4◦C. No Mesna treatment dishes at each timepoint
were used as controls. All subsequent stages were performed in
the same manner as the internalization assay. The level of the
recycled ITGA5 was determined by normalizing the amount of
ITGA5 quantified from dishes treated with Mesna, to the total
ITGA5 on the membranes of the Mesna-untreated cells in the
same period of incubation.
Statistical Analysis
The graphic illustrations and analyses to determine statistical
significance were generated using GraphPad Prism 6.0 software
and Student’s t-tests, respectively. Bar charts show mean values
and the standard error of the mean (±SEM). Asterisks indicate
the statistical significance of P-values: P > 0.05 = ns (not
significant), ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and
∗∗∗∗P < 0.0001.
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FIGURE S1 | (A): PyMT transfected mLMEC pellets from nine different
immortalized EC lines were subjected to DNA extraction and PCR-based
genotyping at the ITGB3 locus. Shown is an agarose gel of P1/P3 and P1/P2
primer products from all EC lines. Lines 1–5 show only a P1/P3 product and are
therefore wild-type (WT) for the ITGB3 locus, whilst lines 6–9 show both a P1/P3
product, and a P1/P2 product, and are therefore heterozygous (β3HET) for the
ITGB3 locus. (B): Western blot analysis of VE-Cadherin and ITGB3 expression in
the same clones shown in (A). HSC70 was used as a loading control. Because
the antibody used for detection of ITGB3 recognizes a non-specific band at
approximately (135kDa), a β3-knockout (NULL) lysate was included as a control
(cell line #10). (C): Left panel shows the densitometric analysis of mean ITGB3
band intensities normalized against HSC70 obtained using ImageJTM [from the
Western blot shown in (B)]. ∗∗P < 0.01. (D): The EC identity of three immortalized
EC lines was re-confirmed by Western blot analysis, immunoblotting against
additional EC markers Pecam-1, Endomucin, ERG and Claudin-5, alongside a
GAPDH loading control and a lymphatic marker Prox-1. (E): ECs were transfected
either with control siRNA or one of four different NRP2-specific siRNAs (01–04)
and incubated for 48 h. EC extracts were then subjected to Western blot analysis
using antibodies against NRP2, NRP1 and HSC70. Except where noted
(Supplementary Figure S3), NRP2 siRNA #03 was used for all subsequent
experiments to silence NRP2 expression. (F): siRNA-transfected ECs were
incubated for the indicated timepoints before being lysed and subjected to
Western blot analysis using antibodies against NRP2 and HSC70. Asterisks
indicate statistical significance from unpaired two-tailed t-tests. (G): Schematic
diagram of the ITGB3 (WT) and (HET) loci, showing where PCR genotyping
primers align. P1 and P3 amplify a wild-type product of 446-bp, whilst P1 and P2
amplify a knockout product of 538-bp.
FIGURE S2 | (A): siRNA-transfected ECs were seeded onto FN and incubated for
30 h. ECs were then re-seeded onto FN-coated coverslips, and allowed to adhere
for 4 h in serum-free media. Media was then replaced with 10 µM BrdU in
complete culture medium, and the cells incubated for 12 h at 37◦C. ECs were
then fixed with 4% PFA, before hydrolyzing the DNA with 1 M HCL. ECs were
permeabilized and blocked with Dako R© Protein Block Serum-Free. ECs were then
incubated with anti-BrdU at 4◦C overnight in a humidified chamber, followed by
incubation in secondary antibody. Coverslips were subsequently mounted and the
number of cells in S-phase (proliferating cells) was determined by dividing the
number of the BrdU-labeled cells by the number of DAPI-labeled cells. n = 19
independent fields of view, containing on average 50 cells per field, per condition.
(B): Adhesion assay performed as described in Figure 2A, however, ECs were
transfected with either control or NRP2 siRNA#04. Bars show mean number of
adhered cells calculated from absorbance readings from 40 wells per condition,
per timepoint, normalized to a 3-h incubation control plate, N = 1. (C):
Accompanying analysis to Figure 2D. The cell area (microns2) was measured
using ImageJTM. Quantification performed on mean data from n ≥ 25 ECs over
N = 3 independent experiments, nsd = not significantly different from unpaired
two-tailed t-test. (D): siRNA-transfected ECs were prepared as described in
Figure 2D legend, measuring mean FA number, FA size and FA distribution,
however, ECs were transfected with either control or NRP2 siRNA#04.
Quantification performed on mean data from n = 15 ECs. Asterisks indicate
statistical significance from an unpaired two-tailed t-test.
FIGURE S3 | (A): Accompanying analysis to Figure 3D. siRNA-transfected ECs
were prepared for immunocytochemistry as described in Figure 2C. Fixed ECs
were incubated in primary antibodies against ITGA5 overnight at 4◦C. ITGA5
length was measured using the ImageJTM software plugin simple neurite tracer.
n = 490 cells per condition, ∗∗∗∗P (0.0001). Asterisks indicate statistical
significance from unpaired two-tailed t-tests. (B): siRNA-transfected ECs from
three different immortalized EC lines were prepared as described in Figure 3D
legend, however, ECs were transfected with either control (top) or NRP2
siRNA#04 (bottom). Panels show representative images from N = 3 independent
lines, n ≥ 10 cells per line. (C): Western blot analysis of cell lysates from both
primary EC clones alongside a lysate from a known fibroblast control cell line. EC
extracts were immunoblotted using antibodies against known EC markers
Endomucin, ERG and Claudin-5, alongside a GAPDH loading control. (D): Primary
ECs were transfected with either ctrl or NRP2 siRNA and prepared for
immunostaining as described in Figure 3E. Panels show representative images
from n = 10 cells per condition from two independent primary EC lines.
TABLE S1 | NRP2-immunoprecipitating label-free quantitative (LFQ) mass
spectrometry list.
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